Back
BioVie, Inc. Vs. Nebius Group NV Industry Stock Comparison
Sell
34
BIVI
BioVie, Inc.
Last Price:
$1.42
Seasonality Move:
-0.12%
Buy
51
NBIS
Nebius Group NV
Last Price:
$108.86
Seasonality Move:
16.36%
Sell
34
BioVie, Inc. (BIVI)
is a Sell
Is BioVie, Inc. a Buy, Sell or Hold?
-
The current BioVie, Inc. [BIVI] share price is $1.42. The Score for BIVI is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
BIVI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $108.82. The Score for NBIS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIVI Stock Price Chart
What is BioVie, Inc.'s stock price today?
-
The BioVie, Inc. share price today is $1.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIVI is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $108.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | 42572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.42) | Buy |
| Bollinger Bands (100): | (1.21 - 1.47) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | 13258215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.12 - 116.9) | Buy |
| Bollinger Bands (100): | (86.58 - 107.22) | Buy |
BIVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.36 | Buy |
| 20-day SMA: | 1.37 | Buy |
| 50-day SMA: | 1.29 | Buy |
| 200-day SMA: | 2.68 | Sell |
| 8-day EMA: | 1.35 | Buy |
| 20-day EMA: | 1.09 | Buy |
| 50-day EMA: | 0.65 | Buy |
| 200-day EMA: | 0.2 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.45 | Buy |
| 20-day SMA: | 108.76 | Buy |
| 50-day SMA: | 99.99 | Buy |
| 200-day SMA: | 89.14 | Buy |
| 8-day EMA: | 105.76 | Buy |
| 20-day EMA: | 106.36 | Buy |
| 50-day EMA: | 102.68 | Buy |
| 200-day EMA: | 86.85 | Buy |
BioVie, Inc. Earnings Growth & BIVI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.45 per share, and a decrease next year of $0.00 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.82 per share, a decrease this year of $0.72 per share, and an increase next year of $1.68 per share.
BioVie, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||